🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the UK / NCT07655895
Active, not recruiting Not applicable

Case Series of Infants With Anterior Ankyloglossia Being Treated by the Sublingual Neonatal Incision Platform Device

NCT07655895 · tracked via the Priya Life Science UK tracker
Sponsor
Europa Life Sciences Limited
Phase
Not applicable
Started
2026-03-10
Last updated
2026-06-18

Condition(s) studied

Ankyloglossia

Investigational drug(s) / intervention(s)

Frenectomy of anterior ankylogossia using the novel device

Frenectomy of anterior ankylogossia using the novel device: Patient treated using the novel device under study

Study summary

A study assessing the feasibility of a novel device designed specifically to treat infant tongue-tie.

Eligibility

Sex
ALL
Min age
1 Week
Max age
12 Weeks
Healthy volunteers
No
Inclusion Criteria: * Anterior ankyloglossia requiring intervention Exclusion Criteria: * Concomitant morphological variation in the oral cavity which could compromise frenectomy Blood dyscrasia Immunocompromise

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tunbridge Wells Hospital Pembury Royal Tunbridge Wells United Kingdom

More Europa Life Sciences Limited trials in the UK

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07655895 on ClinicalTrials.gov ↗ ← All trials in the UK